Stat3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| STAT3 Gene |
|---|
| Symbol | STAT3 |
| Full Name | Signal Transducer and Activator of Transcription 3 |
| Chromosome | 17q21.2 |
| NCBI Gene ID | [6776](https://www.ncbi.nlm.nih.gov/gene/6776) |
| OMIM | [102582](https://www.omim.org/entry/102582) |
| Ensembl ID | ENSG00000168610 |
| UniProt ID | [P40763](https://www.uniprot.org/uniprot/P40763) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease); [Parkinson's Disease](/diseases/parkinsons-disease); [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis); [Multiple Sclerosis](/diseases/multiple-sclerosis) |
The STAT3 (Signal Transducer and Activator of Transcription 3) gene encodes a critical transcription factor that mediates cellular responses to cytokines and growth factors. STAT3 plays dual roles in the central nervous system — promoting neuronal survival under some conditions while contributing to neuroinflammation in others. It is activated in response to interleukin-6 (IL-6), leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), oncostatin M (OSM), and other neuroprotective factors. Dysregulated STAT3 signaling has been implicated in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.
STAT3 is a member of the STAT (Signal Transducer and Activator of Transcription) family of transcription factors. The human STAT3 gene spans approximately 32 kb on chromosome 17q21.2 and encodes a 770-amino acid protein. STAT3 is ubiquitously expressed and can be activated by a wide variety of ligands, making it a central hub for cellular signaling.
| Feature |
Description |
| Gene Symbol |
STAT3 |
| Chromosomal Location |
17q21.2 |
| NCBI Gene ID |
6776 |
| Ensembl ID |
ENSG00000168610 |
| OMIM |
102582 |
| UniProt |
P40763 |
| Protein Length |
770 amino acids |
| Molecular Weight |
~92 kDa |
The STAT3 protein contains several functional domains:
- N-terminal coiled-coil domain (residues 1-130): Mediates protein-protein interactions
- DNA-binding domain (residues 130-315): Binds to DNA response elements
- Linker domain (residues 315-490): Connects DNA-binding to transactivation domain
- SH2 domain (residues 490-580): Mediates dimerization with phosphorylated STAT3
- Transactivation domain (residues 580-770): Recruits transcriptional co-activators
The canonical STAT3 activation pathway involves:
flowchart TD
A["Ligand Binding<br/>IL-6, LIF, CNTF, OSM"] --> B["GP130/JAK Receptor"]
B --> C["JAK Kinase<br/>Phosphorylation"]
C --> D["STAT3 Monomer<br/>Recruitment"]
D --> E["STAT3 Y705<br/>Phosphorylation"]
E --> F["STAT3 Dimerization"]
F --> G["Nuclear Translocation"]
G --> H["DNA Binding<br/>p-STAT3 Response Elements"]
H --> I["Gene Transcription<br/>Acute Phase Proteins, Bcl-2, c-Myc"]
I --> J["Dephosphorylation<br/>Nuclear Export"]
K["Alternative: EGFR, PDGFR"] --> L["TK Phosphorylation"]
L --> E
M["Aβ, Tau, α-Syn"] --> N["Chronic Activation"]
N --> O["Pathological STAT3"]
-
Cytokine Receptors (Classic Activation)
- IL-6 family cytokines (IL-6, IL-11, LIF, CNTF, OSM)
- Uses GP130 co-receptor for signal transduction
-
Receptor Tyrosine Kinases
- Epidermal Growth Factor (EGF)
- Platelet-Derived Growth Factor (PDGF)
- Hepatocyte Growth Factor (HGF)
-
G-Protein Coupled Receptors
- Lysophosphatidic acid (LPA)
- Sphingosine-1-phosphate (S1P)
-
Non-Receptor Tyrosine Kinases
- Src family kinases
- Abl (Bcr-Abl in disease contexts)
STAT3 regulates hundreds of genes involved in:
- Cell survival: Bcl-2, Bcl-xL, Mcl-1, survivin
- Proliferation: c-Myc, cyclin D1
- Inflammation: IL-6, IL-1β, TNF-α, COX-2
- Differentiation: GFAP, Aqp4
- Metabolism: GLUT1, HK2
STAT3 exhibits a paradoxical role in neurodegeneration — protective in some contexts, pathogenic in others:
-
Acute Neuroinflammation Resolution
- STAT3 activation in astrocytes promotes anti-inflammatory gene expression
- Induces IL-10, TGF-β, and neurotrophic factors
- Essential for reactive astrocyte scar formation in injury
-
Neuronal Survival Signaling
- Activation of pro-survival genes (Bcl-2 family)
- Promotes neurite outgrowth and regeneration
- Mediates neurotrophic factor effects
-
Synaptic Plasticity
- Required for LTP in hippocampal neurons
- Regulates AMPA receptor trafficking
- Memory consolidation dependent on STAT3
-
Chronic Neuroinflammation
- Sustained STAT3 activation in microglia drives pro-inflammatory cytokine production
- Creates feed-forward inflammatory loops
- Linked to microglial senescence in aging brain
-
Astrogliosis
- STAT3 is master regulator of reactive astrocyte transformation
- Persistent activation leads to toxic astrocyte phenotypes
- Contributes to neuronal dysfunction
-
Protein Aggregation Interactions
- STAT3 may directly interact with pathological proteins
- Aβ and α-synuclein can activate STAT3
- Creates vicious cycle of inflammation and aggregation
In Alzheimer's disease, STAT3 plays complex roles:
- Amyloid-β mediated activation: Aβ oligomers activate STAT3 in neurons and glia
- Tau pathology: Hyperphosphorylated tau activates STAT3 in neurons
- Neuroinflammation: Elevated IL-6 → STAT3 → chronic inflammation
- Therapeutic targeting: JAK inhibitors reduce Aβ-induced toxicity in models
Key mechanisms:
- Aβ activates JAK2/STAT3 pathway in microglia
- p-STAT3 translocates to nucleus, induces pro-inflammatory cytokines
- Creates positive feedback loop amplifying neuroinflammation
- STAT3 also contributes to APP expression regulation
In Parkinson's disease:
- α-Synuclein pathology: α-synuclein aggregates activate STAT3 in dopaminergic neurons
- Microglial activation: MPTP and 6-OHDA models show STAT3-dependent inflammation
- Neuroprotection: STAT3 activation can protect neurons from oxidative stress
Therapeutic implications:
- JAK/STAT inhibitors reduce microglial activation
- STAT3 siRNA protects dopaminergic neurons
- Paradoxically, STAT3 activation can also be neuroprotective
In ALS:
- Astrocyte reactivity: STAT3 drives toxic astrocyte transformation
- Microglial activation: Sustained inflammatory response
- Motor neuron survival: STAT3 can protect against excitotoxicity
Clinical trials:
- JAK inhibitors (ruxolitinib, tofacitinib) in early-stage trials
- Targeting STAT3 in non-neuronal cells shows promise
- Demyelination: STAT3 involved in oligodendrocyte death
- Remyelination: STAT3 required for oligodendrocyte progenitor differentiation
- Autoimmunity: STAT3 drives Th17 cell differentiation
STAT3 is constitutively expressed in most cell types throughout the body, including neurons, astrocytes, microglia, and oligodendrocytes in the central nervous system. In the brain, STAT3 expression is particularly high in:
- Neurons: Pyramidal cells in cortex and hippocampus, Purkinje cells in cerebellum
- Astrocytes: Particularly reactive astrocytes surrounding lesions
- Microglia: Resting and activated microglial cells
- Oligodendrocytes: Mature oligodendrocytes and precursor cells
| Cell Type |
STAT3 Role |
Key Functions |
| Neurons |
Survival, plasticity |
Neurotrophic signaling, LTP, transcription |
| Astrocytes |
Reactive transformation |
Scar formation, neuroinflammation modulation |
| Microglia |
Inflammatory response |
Cytokine production, phagocytosis regulation |
| Oligodendrocytes |
Differentiation |
Myelination, remyelination |
The STAT3 pathway represents a promising therapeutic target for neurodegenerative diseases:
| Approach |
Agent |
Status |
Mechanism |
| JAK Inhibitors |
Ruxolitinib |
Preclinical |
Inhibit JAK1/2 → reduce STAT3 phosphorylation |
| JAK Inhibitors |
Tofacitinib |
Preclinical |
Broader JAK inhibition |
| STAT3 siRNA |
— |
Research |
Gene silencing to reduce STAT3 expression |
| Peptide Inhibitors |
STAT3-IN-1 |
Research |
Block STAT3 DNA binding |
| Natural Compounds |
Curcumin |
Research |
Modulate STAT3 signaling via multiple pathways |
| Natural Compounds |
Resveratrol |
Research |
SIRT1-dependent STAT3 deacetylation |
- Blood-brain barrier penetration: Challenge for most JAK inhibitors
- Cell-type specificity: Targeting astrocyte vs. microglial STAT3 may have different effects
- Temporal dynamics: Acute vs. chronic STAT3 activation may require different approaches
- Dual nature: Need to balance neuroprotective vs. pathogenic effects
Several animal models have been used to study STAT3 in neurodegeneration:
- STAT3 conditional knockout mice: Neuron-specific deletion reveals role in neuronal survival
- Constitutively active STAT3: Transgenic expression leads to astrocytosis and neuroinflammation
- Astrocyte-specific STAT3 deletion: Impaired reactive astrocytosis and wound healing
- MMP9-STAT3 interaction: MMP9-mediated STAT3 activation contributes to excitotoxicity
- Aβ/STAT3 models: Crossbreeding with APP/PS1 mice shows interaction
- Sullivan et al., STAT3 signaling in neuroinflammation and neurodegenerative disease (2023)
- Zhang et al., Targeting STAT3 in Alzheimer's disease (2024)
- Chen et al., STAT3 in Parkinson's disease models (2023)
- Mazzocco et al., JAK/STAT inhibition in ALS clinical trials (2023)
- Johansson et al., STAT3 in microglia aging and neurodegeneration (2024)
- Park et al., STAT3 in neuroinflammation (2008)
- Chiarugi et al., STAT3 and Alzheimer's disease (2011)
- Liu et al., STAT3 in ALS (2012)
- Nicolas et al., JAK/STAT signaling in the CNS (2013)
- Dziennis et al., STAT3 and neuronal survival (2008)